173 related articles for article (PubMed ID: 24106572)
1. Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.
Ferrinho P; Dramé M; Tumusiime P
Pan Afr Med J; 2013; 15():44. PubMed ID: 24106572
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of the usefulness of external support to immunization coverage in Guinea-Bissau: a Delphi analysis of the GAVI-Alliance cash-based support.
Ferrinho P; Dramé M; Biai S; Lopes O; Sousa Fd; Van Lerberghe W
Rev Soc Bras Med Trop; 2013; 46(1):7-14. PubMed ID: 23563818
[TBL] [Abstract][Full Text] [Related]
3. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
Gandhi G
BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
[TBL] [Abstract][Full Text] [Related]
4. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
[TBL] [Abstract][Full Text] [Related]
6. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
7. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
8. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
9. The GAVI Financing Task Force: one model of partner collaboration.
Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
[TBL] [Abstract][Full Text] [Related]
10. Challenges to implementing Gavi's health system strengthening support in Chad and Cameroon: results from a mixed-methods evaluation.
Dansereau E; Miangotar Y; Squires E; Mimche H; ; ; El Bcheraoui C
Global Health; 2017 Nov; 13(1):83. PubMed ID: 29145871
[TBL] [Abstract][Full Text] [Related]
11. Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia.
Grundy J
Health Policy Plan; 2010 May; 25(3):186-96. PubMed ID: 19926659
[TBL] [Abstract][Full Text] [Related]
12. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
13. GAVI funding meeting exceeds expectations.
Usher AD
Lancet; 2011 Jun; 377(9784):2165-6. PubMed ID: 21714163
[No Abstract] [Full Text] [Related]
14. A global health partnership's use of time-limited support to catalyze health practice change: the case of GAVI's Injection Safety Support.
Levin A; Fang A; Hansen PM; Pyle D; Dia O; Schwalbe N
PLoS One; 2010 Sep; 5(9):e12986. PubMed ID: 20885995
[TBL] [Abstract][Full Text] [Related]
15. General insights on obstacles to dog vaccination in Chad on community and institutional level.
Mbaipago N; Madjadinan A; Amalaman DM; Andrée Ndour P; Zinsstag J; Heitz-Tokpa K; Lechenne M
Front Vet Sci; 2022; 9():866755. PubMed ID: 36311655
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the GAVI Alliance to improving health and reducing poverty.
Lob-Levyt J
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2743-7. PubMed ID: 21893535
[TBL] [Abstract][Full Text] [Related]
17. Perspective and investments in health system strengthening of Gavi, the Vaccine Alliance: a content analysis of health system strengthening-specific funding.
Tsai FJ; Lee H; Fan VY
Int Health; 2016 Jul; 8(4):246-52. PubMed ID: 26612851
[TBL] [Abstract][Full Text] [Related]
18. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
19. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
20. Global rotavirus vaccine introductions and coverage: 2006 - 2016.
Abou-Nader AJ; Sauer MA; Steele AD; Tate JE; Atherly D; Parashar UD; Santosham M; Nelson EAS
Hum Vaccin Immunother; 2018; 14(9):2281-2296. PubMed ID: 29787334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
